Trial Profile
Tau PET Imaging With 18F-AV-1451 in Subjects With MAPT Mutations
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Flortaucipir-F-18 (Primary)
- Indications Dementia
- Focus Diagnostic use
- 22 Mar 2019 Status changed from recruiting to completed.
- 20 Jul 2017 Results (n=7) presented at the Alzheimer's Association International Conference 2017.
- 17 Feb 2016 New trial record